Navigation Links
Biosimulation Market (Drug Discovery & Development) Worth $1.2 Billion by 2017 - New Report by MarketsandMarkets
Date:10/26/2013

(PRWEB) October 26, 2013

The report “Global Biosimulation Market (Insilico Technology Markets for Drug Development) (2012 - 2017)”, defines and segments the global biosimulation market with analysis of forecasting of the global revenue and applications revenue for biosimulation. It also identifies driving and restraining factors for the global biosimulation market with analysis of trends, opportunities, challenges, strengths, weakness and threats. The market is segmented and revenue is forecasted on the basis of major region such as North America, Europe, Asia and Rest of the World. Market is segmented and revenues are forecasted on the basis of application and region.

Browse more than 51 market data tables / figures spread through 130 pages and in-depth TOC on “Global Biosimulation Market”.
http://www.marketsandmarkets.com/Market-Reports/biosimulation-market-838.html

Early buyers will receive 10% customization on this report.

Biosimulation is one the fastest growing technology applied in drug discovery and development process. The decline in output and increase in cost in R&D for new drug discovery and development is a major growth factor for the biosimulation. With many drug candidates failing in the late development stages, pharmaceutical companies are under pressure to reduce cost spent by focusing only on specific experiments, Biosimulation aids in focusing on potentially safe drug candidate and developing it into a successful drug.

The key growth area is application of Pharmacokinetic/pharmacodynamic (PKPD) modeling in pre clinical development it is the most widely used model in drug development process which is driving the growth of biosimulation.

Modelling and simulation are widely used across the drug development process in large and small pharmaceutical companies. Pharmaceutical companies realize that integrating existing knowledge and using quantitative simulation methods offer significant savings in time, money and material over expensive in vitro and in vivo studies. The global market for biosimulation in terms of revenue was estimated to be worth $432.0 million in 2011 and is expected to reach $1.2 billion by 2017, growing at a CAGR of 18.50% from 2012 to 2017.

Browse Related Reports:

Aptamers Market - Technology Trend Analysis by Applications - Therapeutics, Diagnostics, Biosensors, Drug Discovery, Biomarker Discovery, Research Applications with Market Landscape Analysis - Global Forecasts to 2018
http://www.marketsandmarkets.com/Market-Reports/aptamers-technology-market-1167.html

Metabolomics (Biomarker Discovery / Metabolite Detection / Metabolite Profiling) Market by Applications (Drug Discovery / Toxicology Assessment / Diagnosis) and Indications (Oncology / Cardiology / Neurology) - Forecasts from 2012 to 2017
http://www.marketsandmarkets.com/Market-Reports/metabolomics-technology-market-900.html

About MarketsandMarkets
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.

MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals; including advanced materials, automotives and transportation, banking and financial services, biotechnology, chemicals, consumer goods, telecommunications and IT, energy and power, food and beverages, industrial automation, healthcare IT, medical devices, pharmaceuticals, semiconductor and electronics, aerospace & defense.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:

Mr. Rohan
North - Dominion Plaza
17304 Preston Road
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: sales(at)marketsandmarkets(dot)com
Visit MarketsandMarkets Blog @ http://www.marketsandmarketsblog.com/market-reports/healthcare.
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets.

Read the full story at http://www.prweb.com/releases/biosimulation-technology/market/prweb11269322.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Biosimulation Market - New Industry Research Report is Now Available for Pre Order at Transparency Market Research
2. BCC Research Publishes A New Report On Global Markets For Telemedicine Technologies
3. Premium A2P (MT) and P2A (MO) SMS/MMS Messaging Market Volume to Reach 631.5 Billion in 2015 - New Report by MarketsandMarkets
4. Coronary Stents Market to Grow at a CAGR of 9.1% to 2015 in New Research Report at RnRMarketResearch.com
5. Biofertilizers Market (Nitrogen Fixing, Phosphate Solubilizing, Potash Mobilizing) Worth $10.2 Billion by 2017 - New Report by MarketsandMarkets
6. Slim Weight Patch - Scientifically Researched and Proven Weight Loss System Now Available in the Market with 1 Month Extra Supply
7. Retirement Communities in the US Industry Market Research Report from IBISWorld Has Been Updated
8. LME 2013 Experts Provide Insight Into Continued Laser Market Growth
9. TAG Launches Cutting Edge Marketing at Gold's Gym Orlando
10. Antibiotic Resistance 2013: A Global Market Study
11. World Depilatories Market to Reach USD 2.5 Bn by 2018, States GIA in Its Report Available at MarketPublishers.com
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... ... 2016 , ... MEDI+SIGN®, a provider of fully-automated patient monitoring ... for Emergency Departments (ED) has been added to their portfolio. Housed in a ... and with a simplified pallet of information available to the patient, the Digital ...
(Date:12/8/2016)... ... December 08, 2016 , ... The West ... January 1, 2017. The name change aligns the entire company with its ... health care quality. , “We are very proud of the achievements associated with ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... Donuts Franchising Company LLC, announced the first national #QuackGivesBack campaign which supported ... , “This was our first franchise-wide Quack Gives Back initiative, and ...
(Date:12/8/2016)... ... December 08, 2016 , ... Mirixa Corporation , ... and other pharmacist-delivered patient care services, has announced the promotions of Karen Litsinger ... vice president of sales. , Litsinger joined Mirixa in 2008 after serving ...
(Date:12/8/2016)... ... ... David J. Dykeman , Ginger Pigott , and J. Rick ... West, Dec. 12, 2016, at the Fairmont Newport Beach in California. Greenberg Traurig is ... Sciences & Medical Technology Group have been featured speakers at every DeviceTalks conference since ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... Research and Markets has announced the addition of the "Global ... ... market to grow at a CAGR of 6.83% during the period ... growth prospects of the global travel vaccines market for 2016-2020. To ... the sales of various vaccines administered to actively immunize meningococcal disease, ...
(Date:12/9/2016)... 2016  Axovant Sciences Ltd. (NYSE: ... on the treatment of dementia, today announced a ... 2b trial evaluating treatment with intepirdine (RVT-101), combined ... plus placebo in people with mild-to-moderate Alzheimer,s disease. ... to treatment was associated with reduced progression in ...
(Date:12/8/2016)... , Dec. 8, 2016 IRIDEX Corporation (NASDAQ: ... newly issued shares of common stock, $0.01 par value (the ... underwritten public offering.  The final terms of the Offering will ... pricing, and there can be no assurance as to whether ... expects to use the net proceeds it will receive from ...
Breaking Medicine Technology: